Perceptive Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-300,633
Closed -$6.21M 124
2019
Q2
$6.21M Buy
+300,633
New +$6.93M 0.14% 76
2016
Q4
Sell
-16,200
Closed -$367K 212
2016
Q3
$367K Hold
16,200
0.02% 146
2016
Q2
$448K Buy
+16,200
New +$479K 0.03% 130
2016
Q1
Sell
-6,927
Closed -$210K 183
2015
Q4
$210K Buy
+6,927
New +$227K 0.02% 122
2015
Q3
Sell
-8,500
Closed -$492K 184
2015
Q2
$492K Hold
8,500
0.03% 131
2015
Q1
$449K Sell
8,500
-67,413
-89% -$3.15M 0.03% 117
2014
Q4
$3.85M Buy
75,913
+8,413
+12% +$440K 0.32% 64
2014
Q3
$4.01M Buy
+67,500
New +$3.77M 0.41% 50

Other funds holding THC

Perceptive Advisors's THC Position: Q3 2019 in Review

Perceptive Advisors sold out of Tenet Healthcare (THC) in Q3 2019, closing a stake of 300,633 shares — an estimated $6.21M sold.

Perceptive Advisors first reported a position in THC in Q3 2014 and held it in 8 quarters. The position peaked at $6.21M in Q2 2019. 246 funds tracked by Wall St. Rank hold THC as of Q3 2019.

  • Perceptive Advisors reported no remaining Tenet Healthcare position as of Q3 2019 after selling out during the quarter.
  • Perceptive Advisors sold 300,633 Tenet Healthcare shares in Q3 2019, an estimated $6.21M.
  • Perceptive Advisors first reported a position in Tenet Healthcare in Q3 2014 and held it in 8 quarters.
  • Perceptive Advisors's Tenet Healthcare position peaked at $6.21M in Q2 2019.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2019.

Based on Perceptive Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.